Search Within

Samuel Aaron Funt

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (20)
Groups
  1. Biostatistics Service (47)
  2. Department of Medicine (47)
  3. Epidemiology and Biostatistics (47)
  4. Genitourinary Oncology Service (47)
  5. Solid Tumor Oncology Division (47)
  6. Weinberg Fellows (47)

More Groups

People
  1. Dean Bajorin (43)
  2. Jonathan Rosenberg (32)
  3. Gopakumar Iyer (31)
  4. Irina Ostrovnaya (27)
  5. Min Yuen Teo (25)
  6. Hikmat Al-Ahmadie (24)

More People

Years
  1. 2024 (8)
  2. 2023 (3)
  3. 2022 (6)
  4. 2021 (11)
  5. 2020 (6)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. JCO Precision Oncology (2)
  3. Annals of Oncology (1)
  4. Annals of Surgery (1)
  5. Annals of Thoracic Surgery (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Science, Inc. (2)
  3. Lippincott Williams & Wilkins (2)
  4. Nature Publishing Group (2)
  5. Oxford University Press (2)
  6. Wiley Blackwell (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pre-operative chemotherapy (ctx) in plasmacytoid urothelial carcinoma (PUC)
    Meeting Abstract

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Dalbagni, G.; Bochner, B. H.; Funt, S.; Iyer, G.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next generation sequencing of urothelial bladder cancer: Memorial Sloan Kettering Cancer Center experience in 454 patients
    Meeting Abstract

    Isharwal, S.; Audenet, F.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Al-Ahmadie, H.; Cha, E. K.; Donahue, T. F.; Teo, M. Y.; Funt, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Histologic determinants of long-term overall survival in patients (pts) with germ cell tumors (GCT)
    Meeting Abstract

    Funt, S.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save